Laboratorio de Bioinformática, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Boulevard del Maestro esquina Elías Piña, Colonia Narciso Mendoza, 88710 Ciudad Reynosa, Tamaulipas, Mexico.
J Mol Model. 2011 Dec;17(12):3075-84. doi: 10.1007/s00894-011-0962-2. Epub 2011 Mar 1.
In order to identify novel inhibitors of the Helicobacter pylori nickel response regulator (HpNikR) an integrative protocol was performed for half a million compounds retrieved from the ZINC database. We firstly implement a structure-based virtual screening to build a library of potential inhibitors against the HpNikR using a docking analysis (AutoDock Vina). The library was then used to perform a hierarchical clustering of docking poses, based on protein-contact footprints calculation from the multiple conformations given by the AutoDock Vina software, and the drug-protein interaction analyses to identify and remove potential promiscuous compounds likely interacting with human proteins, hence causing drug side effects. 250 drug-like compounds were finally proposed as non-promicuous potential inhibitors for HpNikR. These compounds target the DNA-binding sites of HpNikR so that HpNikR-compound binding could be able to mimic key interactions in the DNA-protein recognition process. HpNikR inhibitors with promising potential against H. pylori could also act against other human bacterial pathogens due to the conservation of targeting motif of NikR involved in DNA-protein interaction.
为了鉴定新型幽门螺杆菌镍反应调节剂(HpNikR)抑制剂,我们对半百万种从 ZINC 数据库中提取的化合物进行了综合筛选。我们首先使用对接分析(AutoDock Vina),基于结构的虚拟筛选构建了针对 HpNikR 的潜在抑制剂库。然后,根据 AutoDock Vina 软件提供的多个构象的蛋白质接触足迹计算,使用对接构象进行层次聚类,并进行药物-蛋白质相互作用分析,以识别和去除可能与人类蛋白质相互作用的潜在混杂化合物,从而导致药物副作用。最后提出了 250 种具有药物样特性的潜在非混杂 HpNikR 抑制剂。这些化合物针对 HpNikR 的 DNA 结合位点,因此 HpNikR-化合物结合能够模拟 DNA-蛋白质识别过程中的关键相互作用。由于涉及 DNA-蛋白质相互作用的 NikR 靶向基序的保守性,具有针对 H. pylori 有潜力的 HpNikR 抑制剂也可能对其他人类细菌病原体起作用。